Patent applications published 5 January 2011
Selected patent applications from the weekly European Patents Bulletin
- Novel compounds advantageous in the treatment of central nervous system diseases and disorders
Aurimmed Pharma 2268140*
- Compounds and methods for reducing uric acid
Wellstat Therapeutics 2268141*
- Use of alginated oligomers in combating biofilms
Algipharma 2268142*
- Novel piperidine derivatives as inhibitors of stearoyl-CoA desaturase
Forest Laboratories Holdings 2268143*
- Indolene anti-cancer agents
Joyant Pharmaceuticals 2268146*
- Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
DSM IP 2268157*
- Cross-linked polymer matrix, in particular for administering active ingredients
Universität Regensberg 2268264*
- Compsns for site-specific delivery of Imatinib and methods of use
Elan Pharma International 2268265* - Process for obtaining powder compsns of Orlistat to be filled into a capsule
Zaklady Faramceutyczne ‘Polpharma’ 2268266*
- Dry transglutaminase compsn
Novo Nordisk 2268267*
- Orally disintegrating compsns of rhein or diacerein
Wockhardt Research Centre 2268268*
- Sulfoalkyl ether cyclodextrin compsns
CyDex Pharmaceuticals 2268269*
- Improved formulations for poorly permeable active pharmaceutical ingredients
Abbott Products 2268270*
- Hand sanitising patch
Lectec 2268271*
- Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
Mount Sinai School of Medicine of New York University 2268272*
- Small-molecule modulators of TRP0P8 activity
Dendreon 2268273*
- Vitamin E derivatives and their uses
Virun 2268274*
- Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use
Abbott Medical Optics 2268275*
- Compsns for the treatment and prevention of infections of the oral cavity
Indena 2268276*
- Use of flavonoide compounds for the prophylaxis and therapy of ischaemic or inflammatory cardiovascular diseases
Boehringer Ingelheim International 2268277*
- Pharmaceutical compsn
Shorr, Robert 2268278*
- Treatment of psoriasis or psoriatic arthritis using cyclopropyl-N-{2-[(1S)-1-(3-
ethoxy-4-methoxyphenyl)-2-methylsulphonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
Celgene 2268279*
- Quinolizidinone M1 receptor positive allosteric modulators
Merck Sharp & Dohme 2268280*
- Thienopyrroles and pyrrolothiazoles as new therapeutic agents
Abbott Laboratories 2268281*
- Liquid formulation for deferiprone with palatable taste
Apotex Technologies 2268282*
- Oral modified-release formulations containing thiazepines
Dexcel 2268283*
- Use of G-rich oligonucleotides for treating neoplastic diseases
Antisoma Research 2268284*
- Therapeutic compounds
Merck Sharp & Dohme 2268285*
- Methods of regulating actin cytoskeletal rearrangement and intercellular gap formulation
The University of North Carolina at Chapel Hill 2268286*
- Method of administering antitumour agent comprising deoxycytidine derivative
Taiho Pharmaceutical; Sasaki, Takuma; Matsuda, Akira 2268287*
- Nucleoside derivatives for treatment of calciviridae infections, including norovirus infections
RFS Pharma; Emory University 2268288*
- Anti-infective agents and uses thereof
Innate Therapeutics 2268289*
- Styrene maleic anhydride based formulation for male contraception and prostate cancer
Guha, Sujoy Kumar 2268290*
- Treatment for the hair regrowth in the bald patches formed by alopecia of the celsi area
Aliotta, Rocco; Aliotto, Nicola 2268291*
- Method and compsns for treatment of cancer
Kornipharm International 2268292*
- Stem cell compsn for inducing transplant tolerance
Smt G R Doshi and Smt K M Mehta Institute of Kidney Diseases and Research Centre 2268293*
- Propolis extract
Gehrlicher Pharmazeutische Extrakte 2268294*
- Activation of innate and adaptive immune responses by a ginseng extract
Afexa Life Sciences 2268295*
- Compsns and method for the diagnosis, prevention and treatment of Alzheimer’s disease
SNU R&DB Foundation 2268296*
- Modified toxins
Angelica Therapeutics 2268297*
- Novel GP96 derived peptides
Compugen 2268298*
- Compsns and method for reducing scar formation in wound healing
MosaMedix 2268299*
- Methods for the inhibition of scarring
Renovo 2268300*
- Erythropoietin and fibronectin compsns for bone regeneration
Remedor Biomed 2268301*
- BMP-7 for use in treating vascular sclerosis
Hruska, Keith; Choi, Eric 2268302*
- Novel uses of VEG xxxB
The University of Bristol 2268303*
- Methods for treating acute myocardial infarction
Orthologic 2268304*
- Oxidised paraoxanase 1 and araoxonade 1/HDL particle number ratio as risk markers for cardiovascular disease
The Cleveland Clinic Foundation 2268305*
- Therapeutic cancer antigens
The Board of Trustees of the University of Illinois 2268306*
- Vaccine
GlaxoSmithKline Biologicals 2268307*
- Vaccine for protection against Lawsonia intracellulars
Intervet International 2268308*
- Improvements in preparation of influenza virus vaccine antigens
Novartis 2268309*
- Use of a type II anti-CD20 antibody with increased antibody dependent cellular cytotoxicity (ADCC) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-Hodgkin’s lymphomas
Roche Glycart 2268310*
- Non-invasive systems and methods for in-situ photobiomodulation
Immunolight; Duke University 2268311*
- Treatment of intervertebral disc degeneration
Tissuegene 2268312*
- YOPM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
Universitätsklinikum Münster 2268313*
- Use of pyrene to carry peptides across the blood brain barrier
Adlyfe 2268314*
- Drug conjugates with polyglycerols
Freie Universität Berlin; KTP Tumorforschungsgesellschaft 2268315*
- Novel siRNA compounds for inhibiting RTP801
Quark Pharmaceuticals 2268316*
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Visen Medical; Merck Sharp & Dohme 2268317*
- A tumour model system to study multi-stage cancer
Council of Scientific and Industrial Research, India 2268318*
- Precursors of lipid metabolism for the diagnosis and treatment of cancer
Universität Ulm 2268319*
- Image-guided therapy of myocardial disease: compsn, manufacturing and applications
The Board of Regents of the University of Texas System 2268320*
- Method of determining alanine transaminase (ALT) activity by 13C-MR detection using hyperpolarised 13-C pyruvate
General Electric; The Regents of the University of California 2268321*
- Interaction control of cationic biocides using labile anionic polyelectrolytes
Alcon Research 2268322*
- Fibrin foam and process
Baxter International 2268323*
- Fibrin foam and process for making
Baxter International 2268324*
- Bioresorbable material
Gottfried Wilhelm Leibniz Universität Hannover 2268325*
- Substituted 1,3-cyclopentadione attenuated endothelial-monocyte interactions
Metaproteomics 2268600*
- Method for preparing difluoroacetic acid and salts thereof
Rhodia Opérations 2268601*
- Method for producing diamonodiphenyl alkanes
Evonik Degussa 2268602*
- Process for the preparation of 2-amino-2-[2-(4-C3-C21-alkyl-phenyl)ethyl]propane-1,3-diols
Novartis 2269603*
- Therapies for cancer using isotopically substituted lysine
Retrotope 2268604*
- Fatty acid derivatives for oral administration endowed with high palatability
Berni Canani, Roberto; Calignano, Antonio; Mazzoni, Orietta; Coruzzo, Anna 2168605*
- 4-dimethylaminobutyric acid derivatives
F Hoffmann-La Roche 2268606*
- Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
Cti Bio 2268607*
- Stabilised nucleic acid dark quencher-fluorophore probes
Biosearch Technologies 2268608*
- Synthesis of a PEG-6 moiety from commercial low-cost chemicals
GE Healthcare 2268609*
- Aminoalkylphenyl antagonists of prostaglandin D2 receptors
Amira Pharmaceuticals 2268611*
- Arylsulphonamide-based matrix metalloprotease inhibitors
Novartis 2268612*
- Inhibitors of cell proliferation and uses thereof
European Molecular Biology Laboratory 2268613*
- Method for producing beta-mercapto carboxylic acids
Showa Denko 2268614*
- Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
Chlorion Pharma 2268616*
- Process for the resolution of isoquinoline derivatives
Recordati Industria Chimica E Farmaceutica 2268617*
- Compounds and compsns as TLR activity modulators
IRM LLC 2268618*
- Fluorinated macrocyclic compounds as hepatitis C virus inhibitors
Enanta Pharmaceuticals 2268619*
- Inhibitors of antigen receptor-induced NF-kappa B activation
Burnham Institute for Medical Research; Human Biomolecular Research Institute 2268620*
- Regioselective preparation of substituted pyrimidines
Boehringer Ingelheim International 2268621*
- Regioselective preparation of substituted pyrimidines
Boehringer Ingelheim International 2268622*
- Quinazoline derivatives as RAF kinase modulators and methods of use thereof
Ambit Biosciences 2268623*
- Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
Merck Patent 2268624*
- Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
Bayer Schering Pharma 2268625*
- 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof
Biotechnologijos Institutas 2268626*
- 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
Rottapharm 2268628*
- Photochromic naphthopyranes having a double-bridged terphenyl sub-unit
Rodenstock 2268629*
- Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
Merck Sharp & Dohme 2268630*
- Aminopiperidinyl derivatives and uses thereof
F Hoffmann-La Roche 2268631*
- Tertiary amine derivatives as phosphodiesterase-4 inhibitors
Chiesi Farmaceutici 2268632*
- Pyrazinone glucokinase activators
F Hoffmann-La Roche 2268633*
- Processes for the preparation of bosentan and related compounds using novel intermediates
Actavis Group 2268634*
- Heterocyclic compounds
Taigen Biotechnology 2268635*
- Gamma secretase modulators
Schering 2268636*
- Traizolopyridineone derivatives for use as stearoyl CoA desaturase inhibitors
Gilead Sciences 2268637*
- Tetrahydronaphthyridines and aza derivatives thereof as histamine H3 receptor antagonists
Evotec 2268638*
- Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate
Teva Pharmaceuticals Industries 2268639*
- Process for preparing enantiomerically pure indolopyridines
4SC 2268640*
- Heterocyclic compounds as adenosine receptor antagonist
Advinus Therapeutics 2268641*
- 1’-substituted carba-nucleoside analogues for antiviral treatment
Gilead Sciences 2268642*
- Dioxalane and dioxolanone fused indolobenxadiazepine HCV NS5B inhibitors
Bristol-Myers Squibb 2268643*
- Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
Boehringer Ingelheim International 2268644*
- Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidines, preparation and use thereof as allosteric modulators of MGLUR
Sanofi-Aventis 2268645*
- Thiazolopyridin-2-yloxy-phenyl and thiazolopyridin-2-yloxy-phenylamines as modulators of leukotriene A4 hydrolase
Janssen Pharmaceutica 2268646*
- Compounds and compsns for the detection and treatment of Alzheimer’s disease and related disorders
The General Hospital Corp 2268647*
- Crystalline (6R,7R)-7-(2-(5-amino-[1,2,4]-thiadiazol-3-yl)-2-[(Z)-trityloxyimino-acetylamino]-3-[(R)-1’-tert-butoxycarbonyl-2-oxo-[1,3]-bipyrrolidinyl-(3E)-ylidone-methyl]-8-oxo-5-thia-1-aza-bicyclo[4,2,0]oct-2-ene-2-carboxylic acid benzhydryl ester, its manufacture and use
Basilea Pharmaceutica 2268648*